Obalon Therapeutics, Inc.

OBLN · NASDAQ
Analyze with AI
12/31/2024
12/31/2020
12/31/2019
12/31/2018
Assets
Cash & Equivalents$693$3,905$14,055$21,187
Short-Term Investments$0$0$0$2,548
Receivables$987$3,150$285$882
Inventory$2,460$0$1,936$1,580
Other Curr. Assets$448$780$1,959$2,450
Total Curr. Assets$4,588$7,835$18,235$28,647
Property Plant & Equip (Net)$154$1,478$2,158$1,739
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$22$0$0$0
Other NC Assets$29$1,304$0$0
Total NC Assets$205$2,782$2,158$1,739
Other Assets$0$0$0$0
Total Assets$4,793$10,617$20,393$30,386
Liabilities
Payables$2,208$615$648$1,159
Short-Term Debt$926$9,930$0$9,930
Tax Payable$0$0$0$0
Deferred Revenue$0$0$424$352
Other Curr. Liab.$1,851-$5,499$2,905$5,790
Total Curr. Liab.$4,985$5,046$3,977$17,231
LT Debt$41$430$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$20$476$567$48
Total NC Liab.$61$906$567$48
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$5,046$5,952$4,544$17,279
Equity
Pref Stock$0$0$0$0
Common Stock$20$8$8$23
Retained Earnings-$642,704-$184,764-$172,430-$148,754
AOCI-$104$0-$2,326-$1,979
Other Equity$642,535$189,421$190,597$163,817
Total Equity-$253$4,665$15,849$13,107
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$4,793$10,617$20,393$30,386
Net Debt$274$6,455-$14,055-$11,257